NATUREX : Ordinary and Extraordinary General Meeting_June 26, 2013

le
0

Ordinary and Extraordinary General Meeting - June 26, 2013
Information available

Press release

Avignon, June 11, 2013 - NATUREX, the world leader in specialty plant-based natural ingredients, informs its shareholders about the availability of the documentation relating to the Ordinary and Extraordinary General Meeting on June 26, 2013.

The shareholders of the Company are convened to the Ordinary and Extraordinary General Meeting:

Wednesday June 26, 2013 at 10:00am
NYSE EURONEXT - Auditorium Cambon
39 rue Cambon
75001 Paris

A notice including the agenda and the final text of the resolutions to be proposed to shareholders for approval has been published in the Official Bulletin (BALO - Bulletin des Annonces Légales Obligatoires) and in a legal newspaper on June 10, 2013. A preliminary notice was published in the Official Bulletin in May 22, 2013.

The documents provided by Article R.225-83 of the Commercial Law (Code de Commerce) are made available to shareholders after the convening of the meeting in accordance with the applicable regulations.

All information on how to participate and vote at this General Meeting and a booklet including the documents specified in Article R.225-81 of the Commercial Law (Code de Commerce) are available on NATUREX website: www.naturex.fr (Investors section> Documents> General meetings).

2012 Reference Document filed in April 30, 2013 with the French Financial Markets Authority (AMF - Autorité des Marchés Financiers) may also be viewed on the Company's website (an English translation will be soon available), including the annual financial report 2012, under Article L 451-1 -2 of the Monetary and Financial Code (Code Monétaire et Financier), the President report on the organization of the board and internal control procedures and the statement concerning fees paid to auditors.

Receive free of charge by e-mail all financial information concerning NATUREX by registering on: www.naturex.com

Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B

Total number of shares comprising the share capital: 7,821,355
ISIN FR0000054694

Naturex is a component of the CAC Small and Gaïa indexes.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.

SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

About Naturex

Naturex is the global leader in speciality plant-based natural ingredients.

The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 1,400 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 20 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).

Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.

Contacts  
Thierry Lambert
Chairman and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89
t.lambert@naturex.com
Thierry Bertrand Lambert
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
t.blambert@naturex.com
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Information réglementée
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition des documents préparatoires à l'AG Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-32411-cp_naturex-110613.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant